Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The latest annual report into maternal deaths, produced by Oxford University researchers, highlights the risk of heart disease among pregnant women.

Pregnant woman © Shutterstock

Pregnant women and those who have recently given birth need to be aware of the symptoms of heart disease, says a major new report from researchers at the University of Oxford.

The latest Confidential Enquiry into Maternal Deaths from the national collaborative programme studying maternal and infant deaths, MBRRACE-UK, commissioned by the Healthcare Quality Improvement Partnership shows that in 2012-14, 8.5 women per 100,000* died during pregnancy or shortly after giving birth. The report, ‘Saving Lives, Improving Mothers’ Care’, highlights that two in every 100,000 died from heart disease, which is the leading cause of women dying in pregnancy or the early weeks after childbirth. There has been no significant change in the overall national maternal death rate since the last report.

Read more

Similar stories

Multi-partner 'OpenMind' consortium to develop technology for new generation of neurostimulation devices

General Research

Investigators at the University of Oxford, University of California San Francisco (UCSF), Brown University and the Mayo Clinic have joined forces to develop open-source technology platforms for a new generation of neurostimulation devices that not only provide stimulation to the brain but also sense, record, and stream brain activity.

Why we must expand newborn screening

General Research

Professor Laurent Servais of the Department of Paeditrics writes for the Oxford Science Blog on why it is important that we become much more efficient in the diagnosis of treatable conditions and in the treatment of these diseases.

New method for cost-effective genome-wide DNA methylation analysis

General Research

Ludwig Cancer Research team build on its TAPS method to develop an alternative to costly whole-genome sequencing for the detection of DNA methylation.

Azithromycin not effective against COVID-19, trial confirms

Clinical Trials General Research

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.